1. Home
  2. PLPC vs SRPT Comparison

PLPC vs SRPT Comparison

Compare PLPC & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Preformed Line Products Company

PLPC

Preformed Line Products Company

HOLD

Current Price

$423.35

Market Cap

2.0B

Sector

Industrials

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$20.61

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLPC
SRPT
Founded
1947
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2001
2000

Fundamental Metrics

Financial Performance
Metric
PLPC
SRPT
Price
$423.35
$20.61
Analyst Decision
Strong Buy
Hold
Analyst Count
1
29
Target Price
$275.00
$25.85
AVG Volume (30 Days)
69.0K
3.0M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
0.25%
N/A
EPS Growth
N/A
N/A
EPS
6.62
2.99
Revenue
N/A
$2,198,237,000.00
Revenue This Year
$17.19
N/A
Revenue Next Year
$7.28
N/A
P/E Ratio
$62.03
$7.36
Revenue Growth
N/A
15.58
52 Week Low
$184.02
$14.68
52 Week High
$504.69
$25.32

Technical Indicators

Market Signals
Indicator
PLPC
SRPT
Relative Strength Index (RSI) 49.08 53.18
Support Level $384.13 $20.12
Resistance Level $405.84 $23.70
Average True Range (ATR) 17.55 1.55
MACD -3.44 0.01
Stochastic Oscillator 37.90 46.15

Price Performance

Historical Comparison
PLPC
SRPT

About PLPC Preformed Line Products Company

Preformed Line Products Co is a designer and manufacturer of products and systems for constructing and maintaining overhead and underground networks for energy, telecommunication, cable operators, data communication, and other industries. The Company's primary products support, protect, connect, terminate, and secure cables and wires. The Company provides helical solutions, connectors, fiber optic and copper splice closures, solar framing applications, and electric vehicle charging station foundations. The Company's customers include public and private energy utilities and communication companies, cable operators, contractors and subcontractors, distributors, and value-added resellers. Geographically, the company operates in four regions: PLP-USA, the Americas, EMEA, and Asia-Pacific.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: